Key terms
About RSLS
ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. It operates through the United States, Australia, Europe, and Rest of World geographical segments. The company was founded in December 2002 and is headquartered in San Clemente, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest RSLS news
Mar 28
8:45am ET
ReShape Lifesciences receives notice of allowance for additional U.S. patent
Mar 04
8:32am ET
ReShape Lifesciences announces cost reduction plan, reorganization
Feb 22
8:45am ET
ReShape Lifesciences announces first surgeries using Lap-Band 2.0 FLEX
Jan 24
8:36am ET
ReShape conducts bariatric surgical fellows training for Lap-Band system
Jan 18
2:08pm ET
Meet ReShape Lifesciences: Fly exclusive interview with CEO Paul Hickey
Jan 18
2:00pm ET
Commercialization of 2.0 Flex to ramp up through 2024, ReShape CEO says
Jan 18
2:00pm ET
GLP-1 drugs helping normalize obesity treatment, ReShape CEO tells The Fly
Jan 18
2:00pm ET
ReShape CEO expects traction on partnership, merger discussions soon
Jan 18
2:00pm ET
ReShape CEO says Lap-Band 2.0’s PMA supplement approval ‘huge’
No recent press releases are available for RSLS
RSLS Financials
Key terms
Ad Feedback
RSLS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
RSLS Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
